PATHOGENESIS OF FILAMENTOUS INFLUENZA VIRUS INFECTION

丝状流感病毒感染的发病机制

基本信息

  • 批准号:
    6534274
  • 负责人:
  • 金额:
    $ 13.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-09-30 至 2004-06-30
  • 项目状态:
    已结题

项目摘要

We have recently shown that the specific amino acids in the M1 and M2 proteins of influenza A virus are important genetic determinants of filamentous virus morphology. In addition, we have demonstrated that the host cell cytoskeletal complex is an important cellular determinant of filamentous virus formation. The objectives of this proposal expand upon these recent observations and focus on determining the cell biological dynamics associated with filamentous influenza virus entry, and on the pathogenic potential of filamentous influenza virus as it relates to spread of infection and severity of disease. In specific aim 1, experiments are described to address specific questions relating to the mechanisms of filamentous virus attachment and entry. Employing radiolabeled and fluorochrome-labeled viral filaments, we will quantitatively examine whether viral filament entry occurs by partial or complete endocytosis or possibly by a phagocytosis-like mechanism. Membrane fusion assays will be used to determine pH requirements and extent of cell fusion of viral filaments. Live cell video microscopy, confocal and electron microscopy will be used to follow the fate of internalized viral filaments and examine whether budding viral filaments can mediate cell-to-cell spread of infection. In specific aim 2, we will focus on the pathogenic potential of filamentous influenza virus. Using primary human nasopharyngeal organ and epithelial cultures we will determine whether infection is restricted to a subpopulation of epithelial cells and determine whether filamentous virus strains have enhanced ciliopathic and tissue damaging capabilities. Using a fluorochrome-based binding assay, we will assess whether viral filaments can enhance bacterial binding to the mucosal epithelium. Using the mouse and ferret animal models, we will compare in vivo the pathogenic potential of genetically similar variants of influenza A/Udorn virus, which differ only in morphology. Pathogenic criteria that will be assessed include: i) the 50 percent minimal infectious dose, ii) tissue specific viral loads iii) tissue-specific histopathology, and iv) rates of weight loss recovery. In the animal studies, we will examine whether filamentous strains promote a descending spread of infection, from an initial localized infection in the nasal tract to the lower respiratory tract. These studies will set the foundation for establishing further determinants of influenza virus pathogenesis and severity of disease in humans.
我们最近发现,甲型流感病毒M1和M2蛋白中的特定氨基酸是丝状病毒形态的重要遗传决定因素。此外,我们还证明了宿主细胞细胞骨架复合体是丝状病毒形成的重要细胞决定因素。这项提案的目标是在最近这些观察的基础上进行扩展,重点是确定与丝状流感病毒进入有关的细胞生物学动力学,以及丝状流感病毒与感染传播和疾病严重程度有关的致病潜力。在具体目标1中,描述了解决与丝状病毒附着和进入机制有关的具体问题的实验。利用放射性标记和荧光标记的病毒细丝,我们将定量检测病毒细丝进入是通过部分或完全内吞还是可能通过吞噬样机制发生。膜融合分析将用于确定病毒细丝的pH要求和细胞融合程度。活细胞视频显微镜、共聚焦显微镜和电子显微镜将被用来跟踪内化的病毒细丝的命运,并检查萌芽的病毒细丝是否可以介导感染在细胞之间的传播。在具体目标2中,我们将重点关注丝状流感病毒的致病潜力。使用原代人类鼻咽器官和上皮细胞培养,我们将确定感染是否仅限于上皮细胞亚群,并确定丝状病毒株是否增强了纤毛病变和组织破坏能力。使用基于荧光色素的结合试验,我们将评估病毒细丝是否可以增强细菌与粘膜上皮的结合。利用小鼠和雪貂的动物模型,我们将在体内比较遗传相似的A/Udorn病毒变异株的致病潜力,这些变异株只在形态上不同。将评估的致病标准包括:i)50%的最小感染剂量,ii)组织特异性病毒载量,iii)组织特异性组织病理学,以及iv)体重减轻恢复率。在动物研究中,我们将检查丝状菌株是否促进感染的下行传播,从最初的鼻道局部感染到下呼吸道。这些研究将为进一步确定流感病毒在人类中的致病机制和疾病严重程度的决定因素奠定基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

P. CHRIS ROBERTS其他文献

P. CHRIS ROBERTS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('P. CHRIS ROBERTS', 18)}}的其他基金

Avian Influenza Virus Vaccines Bearing Immunomodulators
含有免疫调节剂的禽流感病毒疫苗
  • 批准号:
    7230203
  • 财政年份:
    2006
  • 资助金额:
    $ 13.58万
  • 项目类别:
Avian Influenza Virus Vaccines Bearing Immunomodulators
含有免疫调节剂的禽流感病毒疫苗
  • 批准号:
    7384284
  • 财政年份:
    2006
  • 资助金额:
    $ 13.58万
  • 项目类别:
Avian Influenza Virus Vaccines Bearing Immunomodulators
含有免疫调节剂的禽流感病毒疫苗
  • 批准号:
    7093718
  • 财政年份:
    2006
  • 资助金额:
    $ 13.58万
  • 项目类别:
FILAMENTOUS INFLUENZA VIRUS AND MICROBIAL COLONIZATION
丝状流感病毒和微生物定植
  • 批准号:
    6803560
  • 财政年份:
    2003
  • 资助金额:
    $ 13.58万
  • 项目类别:
FILAMENTOUS INFLUENZA VIRUS AND MICROBIAL COLONIZATION
丝状流感病毒和微生物定植
  • 批准号:
    6605076
  • 财政年份:
    2003
  • 资助金额:
    $ 13.58万
  • 项目类别:
PATHOGENESIS OF FILAMENTOUS INFLUENZA VIRUS INFECTION
丝状流感病毒感染的发病机制
  • 批准号:
    6171230
  • 财政年份:
    1999
  • 资助金额:
    $ 13.58万
  • 项目类别:
PATHOGENESIS OF FILAMENTOUS INFLUENZA VIRUS INFECTION
丝状流感病毒感染的发病机制
  • 批准号:
    6637843
  • 财政年份:
    1999
  • 资助金额:
    $ 13.58万
  • 项目类别:
PATHOGENESIS OF FILAMENTOUS INFLUENZA VIRUS INFECTION
丝状流感病毒感染的发病机制
  • 批准号:
    6374547
  • 财政年份:
    1999
  • 资助金额:
    $ 13.58万
  • 项目类别:
PATHOGENESIS OF FILAMENTOUS INFLUENZA VIRUS INFECTION
丝状流感病毒感染的发病机制
  • 批准号:
    2848300
  • 财政年份:
    1999
  • 资助金额:
    $ 13.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了